The Competition Commission in South Africa has launched a formal investigation into leading insulin manufacturers Novo Nordisk and Sanofi Aventis following serious allegations of anti-competitive conduct. The inquiry was initiated after health activists complained about Novo Nordisk’s decision to cease supplying human insulin pens to the country’s Health Department in 2024. This move has forced thousands of diabetic patients to…
Tag: health
-
Concerns arise over R836m oxygen plant roll-out
The Department of Health’s (DoH) R836 million oxygen plant installation project for 55 government hospitals is under scrutiny due to the appointment of Bulkeng (Pty) Ltd. Despite its questionable background, project overseer Independent Development Trust (IDT) awarded Bulkeng a R428 million contract, raising comparisons to the Digital Vibes scandal. Bulkeng, a company with limited experience in medical technology, lacks SAHPRA…